The Australian Office of Drug Control (ODC) has granted Australian medicinal cannabis company Nunyara Pharma a licence to manufacture medicinal cannabis for extracts and tinctures of cannabis and cannabis resin. Founded in 2014 to participate in the emerging Australian medicinal cannabis market, Nunyara submitted licence applications for cultivation and manufacture to the Office of Drug…
Advertisement
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.